Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13249 | 786 | 48.3 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
532 | 14062 | TOLL LIKE RECEPTOR//TOLL LIKE RECEPTORS//CD14 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RENAL MED TRANSPLANT GRP | Address | 3 | 100% | 0% | 3 |
2 | RD DISCOVERY | Address | 2 | 67% | 0% | 2 |
3 | UNSTABLE CAROTID PLAQUE | Author keyword | 2 | 67% | 0% | 2 |
4 | ANIM MODEL | Address | 2 | 18% | 1% | 11 |
5 | INNATE ALLOIMMUNITY | Author keyword | 1 | 100% | 0% | 2 |
6 | MYOCARDIAL I R | Author keyword | 1 | 50% | 0% | 2 |
7 | MOL IMMUNOL PHARMACOL | Address | 1 | 24% | 1% | 4 |
8 | TLR4 POLYMORPHISMS | Author keyword | 1 | 40% | 0% | 2 |
9 | ERITORAN | Author keyword | 1 | 27% | 0% | 3 |
10 | CARDIOVASC CHANNELOPATHY | Address | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UNSTABLE CAROTID PLAQUE | 2 | 67% | 0% | 2 | Search UNSTABLE+CAROTID+PLAQUE | Search UNSTABLE+CAROTID+PLAQUE |
2 | INNATE ALLOIMMUNITY | 1 | 100% | 0% | 2 | Search INNATE+ALLOIMMUNITY | Search INNATE+ALLOIMMUNITY |
3 | MYOCARDIAL I R | 1 | 50% | 0% | 2 | Search MYOCARDIAL+I+R | Search MYOCARDIAL+I+R |
4 | TLR4 POLYMORPHISMS | 1 | 40% | 0% | 2 | Search TLR4+POLYMORPHISMS | Search TLR4+POLYMORPHISMS |
5 | ERITORAN | 1 | 27% | 0% | 3 | Search ERITORAN | Search ERITORAN |
6 | SPARSTOLONIN B | 1 | 33% | 0% | 2 | Search SPARSTOLONIN+B | Search SPARSTOLONIN+B |
7 | ENDOGENOUS LIGANDS | 1 | 17% | 1% | 4 | Search ENDOGENOUS+LIGANDS | Search ENDOGENOUS+LIGANDS |
8 | 1 25 DIHYDROXY VITAMIN D3 | 1 | 50% | 0% | 1 | Search 1++25+DIHYDROXY+VITAMIN+D3 | Search 1++25+DIHYDROXY+VITAMIN+D3 |
9 | ADENOCINE | 1 | 50% | 0% | 1 | Search ADENOCINE | Search ADENOCINE |
10 | ANTIBODIES BLOCKING | 1 | 50% | 0% | 1 | Search ANTIBODIES+BLOCKING | Search ANTIBODIES+BLOCKING |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SIGNAL ADAPTER PROTEIN | 26 | 59% | 4% | 29 |
2 | ASP299GLY POLYMORPHISM | 11 | 27% | 4% | 34 |
3 | MEDIATES ISCHEMIA REPERFUSION INJURY | 11 | 78% | 1% | 7 |
4 | 4 DEFICIENT MICE | 8 | 70% | 1% | 7 |
5 | ACUTE ALLOGRAFT REJECTION | 7 | 19% | 4% | 34 |
6 | RECEPTOR 4 DEFICIENT MICE | 6 | 71% | 1% | 5 |
7 | GENE ASP299GLY POLYMORPHISM | 4 | 56% | 1% | 5 |
8 | PROINFLAMMATORY STATE | 4 | 26% | 2% | 12 |
9 | CHRONIC REJECTION EVENTS | 2 | 40% | 1% | 4 |
10 | EARLY ACTIVATION | 2 | 22% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Emerging Role of Innate Immunity in the Heart and Vascular System For Whom the Cell Tolls | 2011 | 88 | 75 | 53% |
Mechanisms of disease: Toll-like receptors in cardiovascular disease | 2007 | 148 | 74 | 53% |
Toll-like receptors in transplantation: sensing and reacting to injury | 2012 | 24 | 36 | 67% |
Implication of Pattern-Recognition Receptors in Cardiovascular Diseases | 2015 | 1 | 131 | 28% |
Toll-like receptors: sensing and reacting to diabetic injury in the kidney | 2014 | 8 | 135 | 33% |
Endogenous ligands of TLR2 and TLR4: agonists or assistants? | 2010 | 187 | 123 | 17% |
Role of Toll-like receptors in cardiovascular diseases | 2011 | 29 | 54 | 50% |
Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury | 2014 | 10 | 88 | 26% |
Innate immune signaling in cardiac ischemia | 2011 | 70 | 109 | 22% |
The innate immune response in reperfused myocardium | 2012 | 42 | 88 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RENAL MED TRANSPLANT GRP | 3 | 100% | 0.4% | 3 |
2 | RD DISCOVERY | 2 | 67% | 0.3% | 2 |
3 | ANIM MODEL | 2 | 18% | 1.4% | 11 |
4 | MOL IMMUNOL PHARMACOL | 1 | 24% | 0.5% | 4 |
5 | CARDIOVASC CHANNELOPATHY | 1 | 33% | 0.3% | 2 |
6 | HERZKREISLAUF ZENTRUM | 1 | 33% | 0.3% | 2 |
7 | ABORAT TRANSPLANT GRP | 1 | 23% | 0.4% | 3 |
8 | AFFILIATED HOSP 3MED | 1 | 50% | 0.1% | 1 |
9 | BLUMBERG PUBL HLTH | 1 | 50% | 0.1% | 1 |
10 | CARDIAC PHARMACOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204288 | CD14//CD14 POLYMORPHISM//TLR4 POLYMORPHISM |
2 | 0.0000163174 | IMMUNOPATHOL INFECT DIS GROUPING IRG GRI//TLR 3//BIOMETRY MED COMP |
3 | 0.0000124037 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |
4 | 0.0000123211 | TIR DOMAIN//PELLINO//INNATE IMMUN INFLAMMAT |
5 | 0.0000106522 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
6 | 0.0000099511 | HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT |
7 | 0.0000086758 | TOLL LIKE RECEPTOR 9//TOLL LIKE RECEPTOR 3//95D CELL |
8 | 0.0000081790 | UNC93B1//MARY KIRKLAND LUPUS//TLR7 |
9 | 0.0000070425 | WINTERS HEART FAILURE//CARDIAC CACHEXIA//PL CACHEXIA |
10 | 0.0000070331 | SEPTIC CARDIOMYOPATHY//CARDIONOME//MYOCARDIAL DEPRESSION |